Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 835837, 10 pages
http://dx.doi.org/10.1155/2014/835837
Research Article

Maternal Plasma and Amniotic Fluid Chemokines Screening in Fetal Down Syndrome

1Department of Perinatology and Obstetrics, Medical University of Bialystok, Marii Sklodowskiej-Curie 24a, Podlasie, 15-276 Bialystok, Poland
2Department of Reproduction and Gynecological Endocrinology, Medical University of Bialystok, Marii Sklodowskiej-Curie 24a, 15-276 Bialystok, Poland
3Department of Clinical Molecular Biology, Medical University of Bialystok, Waszyngtona 12, 15-269 Bialystok, Poland

Received 12 July 2014; Accepted 23 October 2014; Published 16 November 2014

Academic Editor: Sandra Helena Penha Oliveira

Copyright © 2014 Piotr Laudanski et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. L. Sherman, E. G. Allen, L. H. Bean, and S. B. Freeman, “Epidemiology of Down syndrome,” Mental Retardation and Developmental Disabilities Research Reviews, vol. 13, pp. 221–227, 2007. View at Google Scholar
  2. S. Ghosh, E. Feingold, and S. K. Dey, “Etiology of down syndrome: Evidence for consistent association among altered meiotic recombination, nondisjunction, and maternal age across populations,” American Journal of Medical Genetics A, vol. 149, no. 7, pp. 1415–1420, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. P. A. Benn, J. Ying, T. Beazoglou, and J. F. Egan, “Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results,” Prenatal Diagnosis, vol. 21, pp. 46–51, 2001. View at Publisher · View at Google Scholar
  4. P. Laudanski, A. Lemancewicz, P. Kuc et al., “Chemokines profiling of patients with preterm birth,” Mediators of Inflammation, vol. 2014, Article ID 185758, 7 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Laudanski, A. Lemancewicz, P. Pierzynski, M. Akerlund, and T. Laudanski, “Decreased serum level of macrophage inflammatory chemokine-3β/CCL19 in preterm labor and delivery,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 124, no. 1, pp. 23–26, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Laudanski, G. Raba, P. Kuc, A. Lemancewicz, R. Kisielewski, and T. Laudanski, “Assessment of the selected biochemical markers in predicting preterm labour,” Journal of Maternal-Fetal and Neonatal Medicine, vol. 25, no. 12, pp. 2696–2699, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Kuzmicki, B. Telejko, A. Zonenberg et al., “Circulating Pro- and anti-inflammatory cytokines in polish women with gestational diabetes,” Hormone and Metabolic Research, vol. 40, no. 8, pp. 556–560, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Guven, S. C. Karahan, O. Kandemir, U. Ucar, A. O. Cora, and H. Bozkaya, “Occult inflammation and/or ischemia may be responsible for the false positivity of biochemical Down syndrome screening test,” Journal of Perinatal Medicine, vol. 38, no. 4, pp. 367–371, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. P. G. Nelson, T. Kuddo, E. Y. Song et al., “Selected neurotrophins, neuropeptides, and cytokines: developmental trajectory and concentrations in neonatal blood of children with autism or Down syndrome,” International Journal of Developmental Neuroscience, vol. 24, no. 1, pp. 73–80, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. E. M. Wallace, B. Marjono, D. A. Brown et al., “Maternal serum and amniotic fluid levels of macrophage inhibitory cytokine 1 in Down syndrome and chromosomally normal pregnancies,” Prenatal Diagnosis, vol. 24, no. 3, pp. 224–226, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. A. L. Tranquilli, V. Bezzeccheri, C. Scagnoli, L. Mazzanti, and G. G. Garzetti, “Amniotic levels of vascular endothelial growth factor and nitric oxide at the second trimester in Down's syndrome,” Journal of Maternal-Fetal and Neonatal Medicine, vol. 13, no. 1, pp. 28–31, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. M.-T. Gervasi, R. Romero, G. Bracalente et al., “Midtrimester amniotic fluid concentrations of interleukin-6 and interferon-gamma-inducible protein-10: evidence for heterogeneity of intra-amniotic inflammation and associations with spontaneous early (<32 weeks) and late (>32 weeks) preterm delivery,” Journal of Perinatal Medicine, vol. 40, no. 4, pp. 329–343, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Kuc, P. Laudański, O. Kowalczuk, L. Chyczewski, and T. Laudański, “Expression of selected genes in preterm premature rupture of fetal membranes,” Acta Obstetricia et Gynecologica Scandinavica, vol. 91, no. 8, pp. 936–943, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. S. J. Bromage, A. K. Lang, I. Atkinson, and R. F. Searle, “Abnormal TGFβ levels in the amniotic fluid of Down syndrome pregnancies,” The American Journal of Reproductive Immunology, vol. 44, no. 4, pp. 205–210, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. F. Vesce, C. Scapoli, G. Giovannini et al., “Cytokine imbalance in pregnancies with fetal chromosomal abnormalities,” Human Reproduction, vol. 17, no. 3, pp. 803–808, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. V. Costa, L. Sommese, A. Casamassimi et al., “Impairment of circulating endothelial progenitors in Down syndrome,” BMC Medical Genomics, vol. 3, article 40, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. J. M. Chambers, A. Freeny, and R. M. Heiberger, “Analysis of variance; designed experiments,” in Statistical Models in S, Wadsworth & Brooks/Cole, Pacific Grove, Calif, USA, 1992. View at Google Scholar
  18. F. Wilcoxon, “Probability tables for individual comparisons by ranking methods,” Biometrics. Journal of the Biometric Society, vol. 3, pp. 119–122, 1947. View at Google Scholar · View at MathSciNet · View at Scopus
  19. S. S. Shapiro and R. S. Francia, “An Approximate Analysis of Variance Test for Normality,” 2012.
  20. H. Levene, “Robust tests for equality of variances,” in Contributions to Probability and Statistics: Essays in Honor of Harold Hotelling, vol. 1, pp. 278–292, Stanford University Press, 1960. View at Google Scholar
  21. W. J. Youden, “Index for rating diagnostic tests,” Cancer, vol. 3, no. 1, pp. 32–35, 1950. View at Publisher · View at Google Scholar · View at Scopus
  22. E. B. Wilson, “Probable Inference, The Law of Succession, and Statistical Inference,” 2012.
  23. E. R. DeLong, D. M. DeLong, and D. L. Clarke-Pearson, “Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach,” Biometrics, vol. 44, no. 3, pp. 837–845, 1988. View at Publisher · View at Google Scholar · View at Zentralblatt MATH · View at Scopus
  24. X. Robin, N. Turck, A. Hainard et al., “pROC: an open-source package for R and S+ to analyze and compare ROC curves,” BMC Bioinformatics, vol. 12, article 77, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. GBIF, “Resources—tools and information to support the GBIF community,” 2014.
  26. P. Sheppard, W. Kindsvogel, W. Xu et al., “IL-28, IL-29 and their class II cytokine receptor IL-28R,” Nature Immunology, vol. 4, no. 1, pp. 63–68, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Paulesu, V. Bocci, A. King, and Y. M. Loke, “Immunocytochemical localization of interferons in human trophoblast populations,” Journal of Biological Regulators and Homeostatic Agents, vol. 5, no. 3, pp. 81–85, 1991. View at Google Scholar · View at Scopus
  28. H. Nomiyama, S. Fukuda, M. Iio, S. Tanase, R. Miura, and O. Yoshie, “Organization of the chemokine gene cluster on human chromosome 17q11.2 containing the genes for CC chemokine MPIF-1, HCC-2, HCC-1, LEC, and RANTES,” Journal of Interferon and Cytokine Research, vol. 19, no. 3, pp. 227–234, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. A. D. Luster, J. C. Unkeless, and J. V. Ravetch, “γ-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins,” Nature, vol. 315, no. 6021, pp. 672–676, 1985. View at Publisher · View at Google Scholar · View at Scopus
  30. M. R. Sandhya Rani, G. R. Foster, S. Leung, D. Leaman, G. R. Stark, and R. M. Ransohoff, “Characterization of β-R1, a gene that is selectively induced by interferon β (IFN-β) compared with IFN-α,” Journal of Biological Chemistry, vol. 271, no. 37, pp. 22878–22884, 1996. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Mäkikallio, T. Kaukola, J. Tuimala, S. F. Kingsmore, M. Hallman, and M. Ojaniemi, “Umbilical artery chemokine CCL16 is associated with preterm preeclampsia and fetal growth restriction,” Cytokine, vol. 60, no. 2, pp. 377–384, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. R. L. Jones, N. J. Hannan, T. J. Kaitu'u, J. Zhang, and L. A. Salamonsen, “Identification of chemokines important for leukocyte recruitment to the human endometrium at the times of embryo implantation and menstruation,” The Journal of Clinical Endocrinology & Metabolism, vol. 89, no. 12, pp. 6155–6167, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. S. K. Gantsev, K. Umezawa, D. V. Islamgulov et al., “The role of inflammatory chemokines in lymphoid neoorganogenesis in breast cancer,” Biomedicine and Pharmacotherapy, vol. 67, no. 5, pp. 363–366, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. M. R. Faria, M. S. Hoshida, E. A. V. Ferro, F. Ietta, L. Paulesu, and E. Bevilacqua, “Spatiotemporal patterns of macrophage migration inhibitory factor (Mif) expression in the mouse placenta,” Reproductive Biology and Endocrinology, vol. 8, article 95, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. Q. Zhang, P. Putheti, Q. Zhou, Q. Liu, and W. Gao, “Structures and biological functions of IL-31 and IL-31 receptors,” Cytokine and Growth Factor Reviews, vol. 19, no. 5-6, pp. 347–356, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. J. L. A. Pennings, M. P. H. Koster, W. Rodenburg, P. C. J. I. Schielen, and A. de Vries, “Discovery of novel serum biomarkers for prenatal down syndrome screening by integrative data mining,” PLoS ONE, vol. 4, no. 11, Article ID e8010, 2009. View at Publisher · View at Google Scholar · View at Scopus